Press Releases Year None202320222021202020192018201720162015 February 2, 2023 Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference Read More January 5, 2023 Surface Oncology Announces First Patient Dosed in a Phase 1/2 Study Evaluating SRF114, a Potential Best-In-Class Anti-CCR8 Antibody, in Patients with Advanced Solid Tumors Read More
February 2, 2023 Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference Read More
January 5, 2023 Surface Oncology Announces First Patient Dosed in a Phase 1/2 Study Evaluating SRF114, a Potential Best-In-Class Anti-CCR8 Antibody, in Patients with Advanced Solid Tumors Read More